Usefulness of the tumor markers in the diagnose of idiopathic deep venous thrombosis associated cancer;Utilidad de los marcadores tumorales en el diagnóstico de neoplasia asociada a trombosis venosa profunda idiopática

Anales de Medicina Interna

Volumn 19, Issue 11, 2002, Pages 561-566

  Enguidanos M J ^a   Todoli J A ^a   Saro, E ^a   Salvador, G ^a   Villar, J ^a   Gomez Biedma S ^a   Mico, L ^a   Calabuig, J R ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cancer; Deep venous thrombosis; Screening; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; BETA 2 MICROGLOBULIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER; CANCER INCIDENCE; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MALE; PREDICTION; SQUAMOUS CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOSIS;

EID: 0036857141     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms. Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 1977; 56: 1.
2. Naschitz J, Yeshurun D, Lev LM. Thromboembolism in cancer. Changing trends. Cancer 1993; 71: 1384-90.
3. Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, et al. The occurrence of subsequent malignacy in patients presenting with deep vein thrombosis: Results from a historical cohort study. Thromb Haemost 1998; 79: 19-22.
4. Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer. Semin Thromb Hemost 1999; 25: 131-6
5. Prins MH, Lensing AWA, Hirsh J. Idiopathic deep venous thrombosis. Is a search for malignant disease justified? Arch Intern Med 1994; 154: 1310-2.
6. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venosus thromboembolism and cancer. Lancet 1998; 351: 1077-80.
7. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis idiopathic or pulmonary embolism. N Eng J Med 1998; 338: 1169-73.
8. Prandoni P, Lensing AWA, Büller HR, et al. Deep vein thrombosis and the incidence of subsequent syntomatic malignant disease. N Eng J Med 1992; 327: 1128-33.
9. Monreal M, Lafoz E, Casals A, et al. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991; 67: 541-5.
10. Aderka D, Brown A, Zelikovsky A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 1986; 57: 1846-9.
11. Oefelein MG, Brant M, Crotty K. Idiopathic thromboembolism as the presenting sign of occult prostate cancer. Urology 1998; 51: 775-80.
12. Hung SSJ. Deep vein thrombosis of the arm associated with malignancy. Cancer 1989; 64: 531-5.
13. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 1999; 353: 1167-73.
14. Gabriel F, Labiós M, Brasó JV. Trombosis venosa profunda: Presente y futuro. Med Clin (Barc) 2000; 114: 584-96.
15. Borner OP, Paus E, Nustad K. Tumor markers as seen from the clinical laboratory: Physiological, biochemical and analitical aspects. Scand J Clin Lab Invest 1991; 51(Supl. 206): 12-20.
16. Up dating on tumor markers in tissue and in biological fluids. AM Ballesta, GC Torre, E Bombardieri, M Gion, R. Molina, Torino: Ed. Minerva Médica, 1993 (Italy).
17. Molina R, Filella X, Ballesta AM. Marcadores tumorales: ¿Teoría o realidad? Med Clin (Barc) 1994; 102: 189-95
18. O'Connor N. N Eng J Med 1993; 328: 885-6.
19. Prins MH, Rohan Hettiarachchi RJK, Lensing WA, Hirsh J. Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see? Thromb Haemost 1997; 78: 121-5.
20. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with syntomatic idiopathic deep venous thrombosis. Ann Intern Med 1996; 125: 785-93.
21. Fennerty T. Screening for cancer in venous thromboembolic disease. BMJ 2001; 323 (7315): 704-5.
22. Piccioli A, Prandoni P. Venous thromboembolism as first manifestation of cancer. Acta Haematol 2001; 106: 13-7.